IVM is the common abbreviation for ivermectin, a prescription antiparasitic medication used in both human and veterinary medicine. It works by paralyzing and killing certain parasites, and it has been on the World Health Organization’s List of Essential Medicines since 1987. The discovery of ivermectin’s parent compound earned a Nobel Prize in 2015, and the drug has played a major role in controlling devastating tropical diseases across Africa, Asia, and Latin America.
What Ivermectin Treats in Humans
The FDA approves ivermectin tablets for two specific parasitic worm infections: strongyloidiasis (a roundworm that lives in the intestines) and onchocerciasis (also called river blindness, caused by a worm spread through blackfly bites). These are the only oral tablet indications with full FDA approval.
Topical forms of ivermectin treat different problems entirely. A 1% cream applied to the skin is approved for inflammatory rosacea, a chronic skin condition that causes facial redness and bumps. A 0.5% lotion is approved for head lice. These topical versions work locally on the skin rather than throughout the body.
The WHO’s essential medicines list is broader, recognizing ivermectin for hookworm disease, lymphatic filariasis (a parasitic infection that can cause severe swelling in the limbs), whipworm, roundworm, and scabies. In many tropical countries, ivermectin is used off-label for scabies outbreaks in nursing homes and institutional settings, as well as for certain skin mite conditions.
How It Works
Ivermectin targets a specific type of channel in the nerve and muscle cells of parasites. These channels, found only in invertebrates, control the flow of charged particles into cells. Ivermectin locks them open permanently, flooding the parasite’s cells with signals that cause irreversible paralysis. The parasite can no longer move, feed, or reproduce, and it dies.
This mechanism is what makes ivermectin relatively safe for humans. The channels ivermectin targets simply don’t exist in mammalian nerve and muscle tissue. Humans do have somewhat similar channels in the brain, but ivermectin normally can’t reach them because a protein transporter actively pumps the drug out of the central nervous system before it crosses the blood-brain barrier. This built-in protection gives ivermectin a wide safety margin at prescribed doses.
Veterinary Uses
Ivermectin is one of the most widely used drugs in veterinary medicine. For dogs and cats, it’s a cornerstone of heartworm prevention, typically given as a monthly oral dose. In livestock, it treats and prevents a broad range of parasites. Cattle and sheep receive it as a single injection to eliminate intestinal roundworms and mange mites. Horses take it orally for worm control. Pigs can get it through injections or mixed into feed.
The veterinary formulations come in concentrations designed for animals that may weigh hundreds of kilograms. These products are not interchangeable with human formulations, and the concentrations can be dramatically different from what is safe for people.
Side Effects at Normal Doses
At prescribed human doses, ivermectin is generally well tolerated. The most common side effects in clinical trials are itching (reported by about 25% of patients), headache (around 14%), and dizziness (roughly 8%). These numbers come largely from patients being treated for parasitic worms, where some of the itching and discomfort may actually be the body’s immune response to dying parasites rather than a direct drug effect.
Less common side effects include drowsiness, mild tremor, vertigo, nausea, and diarrhea. For most people taking a single prescribed dose, side effects are mild and short-lived.
Overdose and Toxicity Risks
Ivermectin’s safety profile changes significantly at higher-than-recommended doses. Overdose symptoms can include nausea, vomiting, diarrhea, and low blood pressure, but the more serious concern is neurological toxicity. People who have taken excessive amounts have developed confusion, visual hallucinations, inability to walk, seizures, and in severe cases, coma.
There is also a genetic vulnerability. Some people carry mutations in the ABCB1 gene, which codes for the transporter protein that keeps ivermectin out of the brain. In these individuals, even standard therapeutic doses can cause serious neurological symptoms including loss of coordination, double vision, and altered consciousness. This genetic variant is relatively rare but can make a normally safe dose dangerous.
The Nobel Prize Discovery
Ivermectin traces back to a soil bacterium called Streptomyces avermitilis, discovered by Japanese microbiologist Satoshi Ōmura in the 1970s. Ōmura identified roughly 50 promising bacterial cultures from soil samples, and one of them produced a compound with unusual antiparasitic properties. Irish-born scientist William C. Campbell, working at a pharmaceutical company, showed that this compound was remarkably effective against parasites in animals. His team purified it, named the natural product avermectin, and then chemically modified it into a more potent version: ivermectin.
The two scientists shared half of the 2015 Nobel Prize in Physiology or Medicine for this work. The Nobel committee recognized that ivermectin derivatives had “radically lowered the incidence of river blindness and lymphatic filariasis” and showed effectiveness against a growing list of parasitic diseases. Mass drug administration programs using ivermectin have treated hundreds of millions of people in endemic regions.
Ivermectin and COVID-19
Ivermectin gained widespread public attention during the COVID-19 pandemic when some early, small studies suggested possible antiviral activity. This led to significant public demand for the drug as a COVID-19 treatment. However, larger, well-designed clinical trials did not support those early findings. The FDA has never approved ivermectin for the treatment or prevention of COVID-19, and it remains approved only for its established parasitic and dermatological indications.
During this period, poison control centers saw a sharp increase in calls related to ivermectin misuse, with some people taking veterinary formulations at dangerously high concentrations. The toxicity cases that resulted underscored the difference between a drug that is safe at its intended dose for its intended purpose and one taken outside those boundaries.